Evidence map›Paper›PMID 35391789›Full record

ArticleSchizophrenia research. Cognition2022

Evidence of discontinuity between psychosis-risk and non-clinical samples in the neuroanatomical correlates of social function.

Shalaila S Haas, Gaelle E Doucet, Mathilde Antoniades, Amirhossein Modabbernia, Cheryl M Corcoran, René S Kahn, Joseph Kambeitz, Lana Kambeitz-Ilankovic, Stefan Borgwardt, Paolo Brambilla and 7 more

Open access · goldAbstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 8 countries.

Shalaila S HaasDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.
Gaelle E DoucetInstitute for Human Neuroscience, Boys Town National Research Hospital, 14090 Mother Teresa Lane, Boys Town, NE 68010, USA.
Mathilde AntoniadesCenter for Biomedical Image Computing and Analytics, Perelman School of Medicine, University of Pennsylvania, Philadelphia 19104, USA.
Amirhossein ModabberniaDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.
Cheryl M CorcoranDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.
René S KahnDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.
Joseph KambeitzUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
Lana Kambeitz-IlankovicUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Kerpener Strasse 62, 50937 Cologne, Germany.
Stefan BorgwardtDepartment of Psychiatry, University Psychiatric Clinics (UPK), University of Basel, Wilhelm Klein-Strasse 27, 4002 Basel, Switzerland.
Paolo BrambillaDepartment of Neuroscience and Mental Health, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122 Milano, Italy.
Rachel UpthegroveEarly Intervention Service, Birmingham Womens and Childrens NHS Trust, Steelhouse Lane, Birmingham, B4 6NH, UK.
Stephen J WoodDepartment of Pathophysiology and Mental Health, University of Milan, Via Francesco Sforza 35, 20122 Milano, Italy.
Raimo K R SalokangasDepartment of Psychiatry, University of Turku and Turku University Hospital, FI-20014 Turun yliopisto, Finland.
Jarmo HietalaDepartment of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Moorenstrße 5, 40225 Düsseldorf, Germany.
Eva MeisenzahlMax-Planck Institute of Psychiatry, Kraepelinstraße 2-10, 80804 München, Germany.
Nikolaos KoutsoulerisDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Nussbaumstraße 7, 80336 München, Germany.
Sophia FrangouDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY 10029, USA.
Icahn School of Medicine at Mount Sinai · USUniversity of Milan · ITBoys Town · USHeinrich Heine University Düsseldorf · DEKing's College London · GBLudwig-Maximilians-Universität München · DEMax Planck Institute of Psychiatry · DETurku University Hospital · FIUniversity Hospital Cologne · DEUniversity of Birmingham · GBUniversity of Lübeck · DEUniversity of Pennsylvania · US

Funding

Stress-Induced Aberrations in the Mitochondrial Redox Environment Impact Developing Neural Circuits Supporting Cognitive ControlP20GM144641 · NIGMS · FATHER FLANAGAN'S BOYS' HOME · PI Giorgia Picci · 2022 to 2026
$15.1M
Brain connectivity and the role of myelin in PsychosisR01MH113619 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FRANGOU, SOPHIA · 2018 to 2021
$2.5M
Training the next generation of clinical neuroscientistsT32MH122394 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rene S. Kahn, ANTONIA S NEW · 2020 to 2026
$2.5M
NIGMS NIH HHS P20 GM144641NIMH NIH HHS R01 MH113619NIMH NIH HHS T32 MH122394
6 · The paper itself

Abstract

Objective: Social dysfunction is a major feature of clinical-high-risk states for psychosis (CHR-P). Prior research has identified a neuroanatomical pattern associated with impaired social function outcome in CHR-P. The aim of the current study was to test whether social dysfunction in CHR-P is neurobiologically distinct or in a continuum with the lower end of the normal distribution of individual differences in social functioning. Methods: We used a machine learning classifier to test for the presence of a previously validated brain structural pattern associated with impaired social outcome in CHR-P (CHR-outcome-neurosignature) in the neuroimaging profiles of individuals from two non-clinical samples (total n = 1763) and examined its association with social function, psychopathology and cognition. Results: Although the CHR-outcome-neurosignature could be detected in a subset of the non-clinical samples, it was not associated was adverse social outcomes or higher psychopathology levels. However, participants whose neuroanatomical profiles were highly aligned with the CHR-outcome-neurosignature manifested subtle disadvantage in fluid (P Conclusions: We provide evidence of divergence in brain structural underpinnings of social dysfunction derived from a psychosis-risk enriched population when applied to non-clinical samples. This approach appears promising in identifying brain mechanisms bound to psychosis through comparisons of patient populations to non-clinical samples with the same neuroanatomical profiles.

Indexed as

Clinical high-risk for psychosisGeneral populationNeuroimagingSocial functionSupport vector machine

Identifiers

PMID35391789
PMCPMC8980307
OpenAlexW4223480490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.